NBOMe - A very different kettle of fish. . .

Medical Journal of Australia

Volumn 199, Issue 5, 2013, Pages 322-323

  Caldicott, David G E ^a   Bright, Stephen J ^b   Barratt, Monica J ^c  

^a Calvary Hospital   (Australia)

^b PENINSULA HEALTH   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LYSERGIDE; N METHOXYBENZYL; PSYCHOTROPIC AGENT; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ACUTE TOXICITY; AWARENESS; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG INTOXICATION; DRUG MARKETING; DRUG OVERDOSE; DRUG USE; EMERGENCY WARD; LETTER; PATIENT CARE; TABLET;

BENZYLAMINES; HUMANS; LYSERGIC ACID DIETHYLAMIDE; PHENETHYLAMINES; SUBSTANCE-RELATED DISORDERS;

EID: 84883467830     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.10926     Document Type: Letter

References (5)

1. Ralston N, Davies L. Teen jumps to his death after $1.50 drug hit. Sydney Morning Herald 2013; Jun 6. http://www.smh.com.au/nsw/teen-jumps-to-his-death-after-150-drug-hit-20130606-2nrpe.html (accessed Jul 2013).
2. Bright SJ, Bishop B, Kane R, et al. Kronic hysteria: exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. Int J Drug Policy 2013; 24: 231-237.
3. Braden MR, Parrish JC, Naylor JC, Nichols DE. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol 2006; 70: 1956-1964.
4. Hill SL, Doris T, Gurung S, et al. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clin Tox icol (Phila) 2013; 51: 487-492.
5. Bluelight [online drug discussion forum]. The big and dandy NBOMe-2C-C (25C-NBOMe) thread. http://www.bluelight.ru/vb/threads/518529 (accessed Jul 2013).